- Press releases

Asceneuron CEO Dirk Beher to speak at AAIC 2021

Asceneuron CEO Dirk Beher to speak at Alzheimer’s Association International Conference

- Press releases

Asceneuron Appoints Catherine Moukheibir to its Board of Directors

Asceneuron Appoints Prominent Healthcare Leader Catherine Moukheibir to its Board of Directors

- Press releases

Asceneuron awarded by the Alzheimer’s Drug Discovery Foundation

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

- Event

Asceneuron at Genesis Digital 2020

Asceneuron is sharing their experience on discovering innovative and effective therapeutics in the virtual session "Around the World in Neurodegeneration Drug Discovery".

- Event

Asceneuron panelist at Tau2020

Asceneuron will take part in a panel discussion at the Tau2020 Global Conference on February 12th-13th in Washington, D.C.

- Event

Asceneuron to attend the 38th Annual J.P. Morgan Healthcare Conference

Asceneuron to attend the 38th Annual J.P. Morgan Healthcare Conference taking place January 13-16, 2020 at the Westin St. Francis in San Francisco, CA.

- Event

Asceneuron at Genesis 2019

Asceneuron will participate in the Meeting Biotech Rising Star session, being held on December 11th at Genesis 2019, London.

- News

“A bright future for CNS and Alzheimer’s?”

Read the interview of our CEO Dirk Beher in Pharmaphorum.

- Press releases

Asceneuron appoints Dr Eric Yuen to the Board of Directors

Asceneuron appoints experienced CNS clinician Dr Eric Yuen to the Board of Directors

- News

Asceneuron proudly sponsors Atypical Parkinsonian Syndromes Workshop

As part of its commitment to neurodegenerative disease research and development, Asceneuron proudly sponsors the Atypical Parkinsonian Syndromes Workshop organised by the International Parkinson and Movement Disorder Society (MDS) in May 17-18, 2019 in Munich, Germany.